CClinicalTrials.gg
CompletedNCT05013138Updated Aug 14, 2025

Caregiver Adverse Childhood Experiences (ACEs) in Pediatric Primary Care

An interventional study of Training for ACEs and study procedures and Training on study procedures in Child Development, sponsored by Emory University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-14.

Sponsored by Emory University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
181
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This longitudinal study will evaluate if increased caregiver awareness of their own ACEs through provider-led discussions will lead to improved child health via fewer emergency department, urgent care visits and missed primary care appointments.

Read the detailed description

This longitudinal study will examine whether screening for caregiver adverse childhood experiences (ACEs) and a provider-led discussion of how exposure to ACEs impacts parenting will improve child health outcomes over an 18 month period compared to treatment as usual in a pediatric primary care setting during infant well-child visits. Child health outcomes examined will be rates of emergency department and urgent care visits. Potential protective factors, including parental warmth and resilience will also be examined. The population being studied will include caregivers to infants (ranging 1 week-18 months) receiving care at Mercy Care Clinic (MCC) in Chamblee, Georgia (GA), which primarily serves Hispanic families. Contact will be made by approaching patients present for an infant well-child visit in the clinic. Informed consent will be obtained by a study staff member in the waiting room of the Mercy Care Chamblee Clinic. Electronic or written consent (in English or Spanish based on patient preference) will be obtained. This is not a no-contact study. Data will not be publicly available, but deidentified data will be available upon request beginning 12 months after the study is completed. Only direct study staff will have access to identifying information for participants. Privacy of existing data is not a concern. Interactions will include participant's filling out surveys (or having surveys read aloud to them in their preferred language) and chart review. Those participants who meet with providers randomized to the ACEs discussion will also have a short discussion with their provider about any experienced ACEs and forms of resilience they note on the surveys. Data will be collected in the clinic setting and for follow-up visits by phone or internet based on participant preference.

Topics assessed will include exposure to adverse experiences in childhood, depression and posttraumatic stress disorder symptoms, resilience, and parenting. Each assessment will take less than one hour to complete. All participants will be given a subject identification (ID) number upon consent and all data will be deidentified and only associated with that ID number for the remainder of the study. Medical records will be examined for appointment confirmation (eligibility) and for infant medical visits over the course of the study (outcome variable) and only study staff will have access to identifiable information.

02

Conditions studied

  • Child Development

Keywords

  • Adverse Childhood Experiences
03

In context

Lead sponsor

Emory University is the lead sponsor of 1,386 studies on the registry; 236 are open to participants now.

Of its 229 completed or terminated interventional studies of FDA-regulated products, 174 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Caregivers will be eligible to enroll in the study if they bring children to the MCC for either a 4-month, 6-month, 9-month, 15-month, or 18-month WCC. Notably, we anticipate the majority of participants to be of Hispanic origin and many to be exclusively Spanish-speaking. All Research Assistants (RAs) working directly with caregivers will be bilingual according to Emory Spanish fluency testing. We will solicit expert opinion from faculty that work with these communities and the staff of MCC that work with these patients on a regular basis.

Exclusion criteria

Exclusion Criteria:

  • Caregivers will be excluded if they are unable to speak and read either English or Spanish. Caregivers will also be excluded if they have already been enrolled in the study protocol via another child or prior WCC. Caregivers who are under the age of 18 years will also be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
181 participants (actual)

Study arms

  • Active comparator
    Standard of Care Arm

    During the study period, standard of care providers will continue to provide standard of care treatment(s); however, families receiving care from the standard of care providers will complete all study surveys. Instead of ACEs training, standard of care providers will undergo training on study procedures including obtaining survey instruments from caregivers and proper storage of survey instruments. This training will stress the importance of not reviewing caregiver ACE scores and minimizing possible treatment contamination. However, standard of care providers will still be able to provide resources to the families as part of standard of care.

    Behavioral: Training on study procedures

  • Experimental
    Intervention Arm

    Intervention providers will undergo training for ACEs screening and discussion. Eligible families will be enrolled into the study at the intake of their child's 4-month, 6-month, 9-month, 15-month, or 18-month well child check. Caregivers will complete the intake surveys including demographics, caregiver ACEs, resilience, warmth, PTSD, and depression. The providers will lead a discussion regarding the impact of caregiver ACEs. Patients will be contacted 1-week, 6-months, and 18-months following their enrollment to obtain repeat measures of the survey instruments. At the 18-month time point, the electronic medical record (EMR) will be queried to obtain outcome measures.

    Behavioral: Training for ACEs and study procedures

Interventions

  • BehavioralTraining for ACEs and study procedures

    The providers will lead a resilience-based conversation discussion regarding the impact of caregiver ACEs, after receiving training for ACEs and study procedures. The first training component will provide an overview of ACEs using the ACE Interface Training. The second training component will address the implementation of the caregiver ACEs screening in the clinic.

  • BehavioralTraining on study procedures

    Instead of ACEs training, standard of care providers will undergo training on study procedures including obtaining survey instruments from caregivers and proper storage of survey instruments. This training will stress the importance of not reviewing caregiver ACE scores and minimizing possible treatment contamination.

06

What researchers measure

Primary outcomes

  1. Number of emergency department (ED) visits documented in chart at 18 months post-intervention

    Number of emergency department (ED) visits documented in chart from baseline to 18 months post-intervention

    Time frame: 18 months post-intervention

  2. Number or urgent care (UC) visits documented in chart at 18 months post-intervention

    Number or urgent care (UC) visits documented in chart from baseline to18 months post-intervention

    Time frame: 18 months post-intervention

  3. Number of medical visits at Mercy Care at 18 months post-intervention

    Number of medical visits at Mercy Care over the course of the study period will be obtained from baseline to 18 months post-intervention.

    Time frame: 18 months post-intervention

Secondary outcomes

  1. Change in Primary Care PTSD score for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) from Baseline Caregiver's PTSD symptoms due to ACEs screening

    The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) is a 5-item screen designed for use in primary care will assess for presence of PTSD symptoms. This measure will be used to evaluate baseline PTSD symptoms and changes in symptoms as a result of ACEs intervention. The total score is the sum of "yes" responses. Possible range is 0 to 5. Lower score correlates with better outcome.

    Time frame: Baseline, 1 week post-intervention, 6 months follow up, 18 months follow up

  2. Change in Brief Resilience Scale score from baseline

    The investigators will utilize the Brief Resilience Scale (BRS) that focuses on an individual's ability to bounce back from stress. It includes 6 items for caregivers to answer, with the total ranging from 6-30. Higher scores indicate greater levels of resilience. The Brief Resilience Score will be examined as a potential mediator between provider-led ACEs discussion and child health outcomes.

    Time frame: Baseline, 6 months follow up, 18 months follow up

  3. Change in Parenting Questionnaire (PQ) warmth subscale (PQ-warmth) score from Baseline

    The PQ (McCabe \& Clark, 1999 )is a 50-item parent self-report of parenting practices, including warmth; that was modified to include only 13 items relevant for young children. The warmth subscale total ranges from 13-65. Higher scores indicate greater parental warmth. Parental warmth will be examined as a potential mediator between provider-led ACEs discussion and child health outcomes.

    Time frame: Baseline, 6 months follow up, 18 months follow up

  4. Rate of referrals to Division of Family and Child Services (DFACS) at 18 months post-intervention

    Number of referrals to DFACS will be obtained during follow up period (from baseline to 18 months post-intervention).

    Time frame: 18 months post-intervention

  5. Attendance at well child check (WCC) visits at 18 months post-intervention

    Number of visits at WCC be obtained during follow up period (from baseline to 18 months post-intervention).

    Time frame: 18 months post-intervention

  6. Rate of referrals to non-DFACS services at 18 months post-intervention

    Number of referrals to non-DFACS will be obtained during follow up period (from baseline to 18 months post-intervention).

    Time frame: 18 months post-intervention

  7. Rate of clinic-based social worker visits at 18 months post-intervention

    Number of clinic-based social worker visits will be obtained during follow up period (from baseline to 18 months post-intervention).

    Time frame: 18 months post-intervention

  8. Subjective experience of caregiver ACEs screening on clinic staff at baseline

    It will be assessed with a brief qualitative questionnaire. The investigators will ask if staff felt that the ACEs screening negatively/neutral/positively impacted patient experience and staff experience of well-child visits. Scores will range from -1 to +1 for each item and total scores may range from -2 to +2 with higher scores reflecting a more positive outcome.

    Time frame: Baseline

07

Study locations

1 site
  • Mercy Care Chamblee
    Chamblee, Georgia 30341, United States
08

References and documents

Study documents

  • Informed consent form · Aug 25, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Data will not be publicly available, but deidentified data will be available upon request beginning 12 months after the study is completed. Deidentified data files, the data dictionary, and the final protocol will be shared via Emory Dataverse, which is a long-term repository hosted within the University of North Carolina (UNC) Dataverse (listed in the global Registry of Research Data Repositories \[re3data.org\]).

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05013138
Lead sponsor
Emory University
Collaborators
Centers for Disease Control and Prevention
Responsible party
Abigail Lott (Assistant Professor, Emory University) — Principal investigator
First posted
Aug 19, 2021
Start date
Apr 29, 2022
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025
Last update
Aug 14, 2025

Study contacts

Abigail Lott, PhD, ABPP
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion